Presentation of FEMOFLOR® SCREEN during the First National Conference on Innovation in Obstetrics and Gynecology


    RIDACOM will take part in the First National Conference on Innovations in Obstetrics and Gynecology, which will be held in the period 25-28.06.2020 in hotel RIU HELIOS PARADISE, Sunny Beach. In order to improve our capabilities and knowledge, which will contribute to better screening and treatment of the delicate part of the population, as well as to science as a whole, the topics covered will be:

    ♀️News in the gynecological operative methodology

    ♀️Endoscopic and robotic gynecological surgery

    ♀️Novelties in the conservative treatment of gynecological diseases

    ♀️Innovative screening methods in obstetrics and gynecology

    ♀️Innovative instrumental and hardware technologies in the diagnosis and treatment of gynecological diseases

    ♀️Other topics related to the daily practice of obstetricians and gynecologists.

    RIDACOM dedicates its participation to women's health and current issues affecting a large percentage of women - vaginal dysbiosis and screening for sexually transmitted infections. We are going to present a survey based on FEMOFLOR® SCREEN - a modern diagnostic method for quantitative assessment of vaginal microflora and detection of sexually transmitted infections.

    What is FEMOFLOR®?

    FEMOFLOR® is a modern molecular diagnostic test based on Real-Time PCR technology, allowing complex analysis and evaluation of the vaginal microflora, diagnosis of dysbiosis and detection of sexually transmitted infections. For the first time, with just one test, it is possible to determine the microbial composition and the relationships between microorganisms in the female urogenital tract.

    In our study, conducted with the participation of 114 women from Sofia district, which was carried out with the assistance of specialists from the University Hospital "Alexandrovska", some of the following statements were confirmed:

    ♀️Conditions of absolute normocenosis (> 80%), conditional normocenosis (> 80%), moderate dysbiosis (20 - 80%) and acute dysbiosis (<20%) were found in the participants.

    ♀️In a large proportion of women, the presence of Ureplasma spp./ Mycoplasma hominis is observed in clinically significant values.

    ♀️Less than half of women have Candida fungi with increased concentrations in their urogenital tract.

    ♀️The presence of opportunistic pathogens is considered comprehensively and the application of drug treatment strongly depends on the concentration and number of microorganisms inhabiting the female urogenital tract.

    ♀️Sexually transmitted infections were found in 13% of the women surveyed.

    Thank you for your support and we look forward to seeing you!